This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

2 months ago 12
ARTICLE AD BOX
Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.
Read Entire Article
  1. Homepage
  2. Finance
  3. This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

Related

Southwest says assigned seats will make it more profitable this year, as stock rallies

Southwest says assigned seats will make it more profitable t...

22 minutes ago 0
10,000 flights canceled, a $200 million hit from the storm and a plunging stock: American Airlines’ bad week

10,000 flights canceled, a $200 million hit from the storm a...

1 hour ago 0
How do I open a ‘Trump account’? The IRS has one simple solution for you.

How do I open a ‘Trump account’? The IRS has one simple solu...

1 hour ago 0

Trending

1. dtf st louis
2. lisd
3. sporting
4. jillian michaels
5. brandon sanderson
6. dcps
7. pafos fc
8. sporting clube de portugal
9. olympique de marseille
10. fk bodø/glimt

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

11 months ago 502
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

11 months ago 462
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

10 months ago 441
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

11 months ago 394
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

11 months ago 348
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2026. All rights are reserved